Literature DB >> 19157746

Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS.

Britt Jansson1, Matti Karvanen, Otto Cars, Diamantis Plachouras, Lena E Friberg.   

Abstract

An analytical method for quantitation of colistin A and colistin B in plasma and culture medium is described. After protein precipitation with acetonitrile (ACN) containing 0.1% trifluoroacetic acid (TFA), the supernatants were diluted with 0.03% TFA. The compounds were separated on an Ultrasphere C18 column, 4.6 mm x 250 mm, 5 microm particle size with a mobile phase consisting of 25% ACN in 0.03% TFA and detected with tandem mass spectrometry. The instrument was operating in ESI negative ion mode and the precursor-product ion pairs were m/z 1167.7-->1079.6 for colistin A and m/z 1153.7-->1065.6 for colistin B. The lower limit of quantification (LLOQ) for 100 microL plasma was 19.4 and 10.5 ng/mL for colistin A and B, respectively, with CV <6.2% and accuracy <+/-12.6%. For culture medium (50 microL+50 microL plasma), LLOQ was 24.2 and 13.2 ng/mL for colistin A and B, respectively, with CV <11.4% and accuracy <+/-8.1%. The quick sample work-up method allows for determination of colistin A and B in clinical samples without causing hydrolysis of the prodrug colistin methanesulfonate (CMS).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19157746     DOI: 10.1016/j.jpba.2008.12.016

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  21 in total

1.  Serum and cerebrospinal fluid levels of colistin in pediatric patients.

Authors:  Charalampos Antachopoulos; Matti Karvanen; Elias Iosifidis; Britt Jansson; Diamantis Plachouras; Otto Cars; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

2.  Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry.

Authors:  Patrice Gobin; Florian Lemaître; Sandrine Marchand; William Couet; Jean-Christophe Olivier
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

3.  Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill.

Authors:  Ami F Mohamed; Ilias Karaiskos; Diamantis Plachouras; Matti Karvanen; Konstantinos Pontikis; Britt Jansson; Evangelos Papadomichelakis; Anastasia Antoniadou; Helen Giamarellou; Apostolos Armaganidis; Otto Cars; Lena E Friberg
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

4.  Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration.

Authors:  Matti Karvanen; Diamantis Plachouras; Lena E Friberg; Elisabeth Paramythiotou; Evangelos Papadomichelakis; Ilias Karaiskos; Iraklis Tsangaris; Apostolos Armaganidis; Otto Cars; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

5.  Population pharmacokinetic analysis of colistin in burn patients.

Authors:  Jongtae Lee; Seunghoon Han; Sangil Jeon; Taegon Hong; Wonkeun Song; Heungjeong Woo; Dong-Seok Yim
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

6.  Colistin Is Extensively Lost during Standard In Vitro Experimental Conditions.

Authors:  Matti Karvanen; Christer Malmberg; Pernilla Lagerbäck; Lena E Friberg; Otto Cars
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

7.  Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique.

Authors:  Liang Jin; Jian Li; Roger L Nation; Joseph A Nicolazzo
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

8.  Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model.

Authors:  Guihong Chai; Heejun Park; Shihui Yu; Fanfan Zhou; Jian Li; Qingguo Xu; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2019-08-12       Impact factor: 5.875

Review 9.  'Old' antibiotics for emerging multidrug-resistant bacteria.

Authors:  Phillip J Bergen; Cornelia B Landersdorfer; Hee Ji Lee; Jian Li; Roger L Nation
Journal:  Curr Opin Infect Dis       Date:  2012-12       Impact factor: 4.915

10.  Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.

Authors:  Ilias Karaiskos; Lena E Friberg; Konstantinos Pontikis; Konstantinos Ioannidis; Vasiliki Tsagkari; Lamprini Galani; Eirini Kostakou; Fotini Baziaka; Charalambos Paskalis; Antonia Koutsoukou; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.